Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

G R Wilkinson

Showing results (111-120 of 190) with videos related to

Pageof 19
Sort By:
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1986
Oxidative metabolism of encainide: polymorphism, pharmacokinetics and clinical considerationsC B McAllister, H T Wolfenden, W S Aslanian, et al.
Clinical Pharmacology and Therapeutics|July 1, 1979
Effect of aging and cigarette smoking on antipyrine and indocyanine green eliminationA J Wood, R E Vestal, G R Wilkinson, et al.
Clinical Pharmacology and Therapeutics|June 1, 1982
Furosemide disposition in cirrhosisR K Verbeeck, R V Patwardhan, J P Villeneuve, et al.
Journal of Chromatography|April 13, 1984
Direct enantiomeric resolution of mephenytoin and its N-demethylated metabolite in plasma and blood using chiral capillary gas chromatographyP J Wedlund, B J Sweetman, C B McAllister, et al.
British Journal of Clinical Pharmacology|October 1, 1977
Biological determinants of propranolol disposition in normal subjects and patients with cirrhosis [proceedings]R A Branch, D M Kornhauser, D G Shand, et al.
Clinical Pharmacokinetics|November 1, 1978
The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administrationA J Wood, D M Kornhauser, G R Wilkinson, et al.
Circulation|February 2, 1999
Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine [seecomments]M F Fromm, R B Kim, C M Stein, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1988
Brain uptake of benzodiazepines: effects of lipophilicity and plasma protein bindingD R Jones, S D Hall, E K Jackson, et al.
Clinical Pharmacology and Therapeutics|December 1, 1984
Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphismP J Wedlund, W S Aslanian, C B McAllister, et al.
Clinical Pharmacology and Therapeutics|July 1, 1979
Effects of age and cigarette smoking on propranolol dispositionR E Vestal, A J Wood, R A Branch, et al.
Pageof 19

Showing results (111-120 of 190) with videos related to

Sort By:
Pageof 19
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|May 1, 1986
Oxidative metabolism of encainide: polymorphism, pharmacokinetics and clinical considerationsC B McAllister, H T Wolfenden, W S Aslanian, et al.
Clinical Pharmacology and Therapeutics|July 1, 1979
Effect of aging and cigarette smoking on antipyrine and indocyanine green eliminationA J Wood, R E Vestal, G R Wilkinson, et al.
Clinical Pharmacology and Therapeutics|June 1, 1982
Furosemide disposition in cirrhosisR K Verbeeck, R V Patwardhan, J P Villeneuve, et al.
Journal of Chromatography|April 13, 1984
Direct enantiomeric resolution of mephenytoin and its N-demethylated metabolite in plasma and blood using chiral capillary gas chromatographyP J Wedlund, B J Sweetman, C B McAllister, et al.
British Journal of Clinical Pharmacology|October 1, 1977
Biological determinants of propranolol disposition in normal subjects and patients with cirrhosis [proceedings]R A Branch, D M Kornhauser, D G Shand, et al.
Clinical Pharmacokinetics|November 1, 1978
The influence of cirrhosis on steady-state blood concentrations of unbound propranolol after oral administrationA J Wood, D M Kornhauser, G R Wilkinson, et al.
Circulation|February 2, 1999
Inhibition of P-glycoprotein-mediated drug transport: A unifying mechanism to explain the interaction between digoxin and quinidine [seecomments]M F Fromm, R B Kim, C M Stein, et al.
The Journal of Pharmacology and Experimental Therapeutics|June 1, 1988
Brain uptake of benzodiazepines: effects of lipophilicity and plasma protein bindingD R Jones, S D Hall, E K Jackson, et al.
Clinical Pharmacology and Therapeutics|December 1, 1984
Mephenytoin hydroxylation deficiency in Caucasians: frequency of a new oxidative drug metabolism polymorphismP J Wedlund, W S Aslanian, C B McAllister, et al.
Clinical Pharmacology and Therapeutics|July 1, 1979
Effects of age and cigarette smoking on propranolol dispositionR E Vestal, A J Wood, R A Branch, et al.
Pageof 19